BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9086466)

  • 21. Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins.
    Montine KS; Bassett CN; Ou JJ; Markesbery WR; Swift LL; Montine TJ
    J Lipid Res; 1998 Dec; 39(12):2443-51. PubMed ID: 9831633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer's Disease.
    Schmidt C; Gerlach N; Schmitz M; Thom T; Kramer K; Friede T; Zerr I
    J Alzheimers Dis; 2015; 48(1):189-96. PubMed ID: 26401939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
    Vijayaraghavan S; Maetzler W; Reimold M; Lithner CU; Liepelt-Scarfone I; Berg D; Darreh-Shori T
    Alzheimers Dement; 2014 Sep; 10(5):530-540.e1. PubMed ID: 23978325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients.
    Terrisse L; Poirier J; Bertrand P; Merched A; Visvikis S; Siest G; Milne R; Rassart E
    J Neurochem; 1998 Oct; 71(4):1643-50. PubMed ID: 9751198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
    Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
    Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.
    Motter R; Vigo-Pelfrey C; Kholodenko D; Barbour R; Johnson-Wood K; Galasko D; Chang L; Miller B; Clark C; Green R
    Ann Neurol; 1995 Oct; 38(4):643-8. PubMed ID: 7574461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
    Johansson P; Almqvist EG; Bjerke M; Wallin A; Johansson JO; Andreasson U; Blennow K; Zetterberg H; Svensson J
    J Alzheimers Dis; 2017; 59(3):1017-1026. PubMed ID: 28697566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
    Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
    J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele.
    Padayachee ER; Zetterberg H; Portelius E; Borén J; Molinuevo JL; Andreasen N; Cukalevski R; Linse S; Blennow K; Andreasson U
    Brain Res; 2016 Nov; 1651():11-16. PubMed ID: 27653981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal beta-amyloid ((1-42)) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline.
    Riemenschneider M; Schmolke M; Lautenschlager N; Guder WG; Vanderstichele H; Vanmechelen E; Kurz A
    Neurosci Lett; 2000 Apr; 284(1-2):85-8. PubMed ID: 10771168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: a possible role for apolipoprotein E in Alzheimer's disease.
    Aizawa Y; Fukatsu R; Takamaru Y; Tsuzuki K; Chiba H; Kobayashi K; Fujii N; Takahata N
    Brain Res; 1997 Sep; 768(1-2):208-14. PubMed ID: 9369317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease.
    Lefranc D; Vermersch P; Dallongeville J; Daems-Monpeurt C; Petit H; Delacourte A
    Neurosci Lett; 1996 Jul; 212(2):91-4. PubMed ID: 8832646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Apolipoprotein E function in the nervous system].
    Czyzewski K; Pfeffer A; Barcikowska M
    Neurol Neurochir Pol; 1998; 32(1):125-32. PubMed ID: 9631384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
    Gabriel AJ; Almeida MR; Ribeiro MH; Durães J; Tábuas-Pereira M; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
    Neurosci Lett; 2017 Feb; 641():101-106. PubMed ID: 28108398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid apolipoprotein E concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease.
    Schmidt C; Becker H; Zerr I
    Am J Alzheimers Dis Other Demen; 2014 Feb; 29(1):54-60. PubMed ID: 24277910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid apolipoprotein E concentration and progression of Alzheimer's disease.
    Schmidt C; Gerlach N; Peter C; Gherib K; Lange K; Friede T; Zerr I
    J Alzheimers Dis; 2015; 43(4):1229-36. PubMed ID: 25125466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease.
    Kanai M; Shizuka M; Urakami K; Matsubara E; Harigaya Y; Okamoto K; Shoji M
    Neurosci Lett; 1999 May; 267(1):65-8. PubMed ID: 10400250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.